Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Andrée Dutreix"'
Publikováno v:
Strahlentherapie und Onkologie. 177:383-393
In 1998 an ESTRO Quality Assurance Network for radiotherapy (EQUAL) has been set up for 25 European countries for photon and electron beams in reference and non-reference conditions.Measurements are done using LiF powder (DTL937-Philitech, France) th
Autor:
A Björeland, Hans Svensson, D Marre, Jean Chavaudra, Andrée Dutreix, André Bridier, I. Ferreira
Publikováno v:
Physics in Medicine and Biology. 45:3657-3674
Absorbed dose determination with thermoluminescent dosimeters (TLDs) generally relies on calibration in 60Co gamma-ray reference beams. The energy correction factor fCo(E) for electron beams takes into account the difference between the response of t
Autor:
Andrée Dutreix, Dietmar Georg
Publikováno v:
Physics in Medicine and Biology. 44:817-832
Mini-phantoms are an important tool for measurement of basic head scatter parameters in high-energy photon beams, and recently they have also been used for beam quality specification. Therefore the feasibility and reliability of basic beam parameter
Publikováno v:
Radiotherapy and Oncology. 18:16-29
Basic dosimetry as well as patient dosimetry are considered. The following items concerning the basic beam dosimetry are discussed: dosimetry calibration, phantom material, beam quality and depth dose measurements in TBI conditions. Dose to the patie
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 6(1)
State of the ArtThe EQUAL Dosimetry audit service, set-up by the ESTRO in 1998aaThe present ESTRO-EQUAL Project (MORQA) has been funded by an EU contract., is wellknown through large numbers of TL-dosimeters sent to hospitals to be irradiated in clin
Autor:
A. Barrett, Hans Svensson, Andrée Dutreix, G. Heeren, Jack L.M. Venselaar, M. Baumann, D. Huyskens, Ben J. Mijnheer, E. Lartgau
Publikováno v:
Reports of Practical Oncology & Radiotherapy. 6(1):35-36
In most medical specialties the success rate and outcome of treatment coincide and can be measured immediately. This is not the case for radiotherapy where debilitating of even lethal side effects may show up as late as 18 years after treatment. To d
Autor:
D. Chassagne, M. Albano, C. Haie, Guy Michel, M. Prade, M. Masselot, G.R. Kerr, I. Kunkler, Gerbaulet A, Catherine Lhommé, Andrée Dutreix
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 23(2)
From January 1975 to December 1984, 441 patients were treated by combined radiotherapy and surgery at the Institut Gustave Roussy (IGR) for Stage IB (288) and II (proximal) (103) carcinoma of the uterine cervix. Standard treatment consisted of pre-op